Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke

Abstract

Serum GFAP can reliably detect ICH in the acute phase of stroke. Further evaluation of the usefulness of GFAP as an early diagnostic marker of ICH is now required, with the aim of optimising cause specific emergency management.